191868-24-3 Usage
Uses
Used in Oncology:
1-[4-(AMINOMETHYL)PHENYL]-N-METHYLMETHANESULFONAMIDE is used as an antineoplastic agent for its potential to treat various types of cancer, including solid tumors and hematological malignancies. It targets the inhibition of carbonic anhydrase, which is involved in pH regulation in tissues, thereby affecting the tumor microenvironment and potentially limiting cancer progression.
Used in Cancer Research:
In the field of cancer research, 1-[4-(AMINOMETHYL)PHENYL]-N-METHYLMETHANESULFONAMIDE is used as a subject of investigation for its potential efficacy in treating cancer. Its relatively low toxicity compared to other antineoplastic agents makes it a promising candidate for further study and development.
Used in Drug Development:
1-[4-(AMINOMETHYL)PHENYL]-N-METHYLMETHANESULFONAMIDE is utilized in drug development as a potential lead compound for the creation of new cancer therapeutics. Its mechanism of action through carbonic anhydrase inhibition offers a unique approach to cancer treatment, and ongoing research aims to optimize its properties for clinical use.
Check Digit Verification of cas no
The CAS Registry Mumber 191868-24-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,1,8,6 and 8 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 191868-24:
(8*1)+(7*9)+(6*1)+(5*8)+(4*6)+(3*8)+(2*2)+(1*4)=173
173 % 10 = 3
So 191868-24-3 is a valid CAS Registry Number.
191868-24-3Relevant academic research and scientific papers
Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
-
, (2008/06/13)
NPY-antagonistic compounds of the formula STR1 Exemplary are: (A) (R)-N-[[4-(Aminocarbonylaminomethyl)phenyl]methyl]-N 2-bis(4-hydroxyphenyl)acetyl]-argininamide-trifluoracetate;(B) (R)-N-[[4-(Aminocarbonylaminomethyl)phenyl]methyl]-N 2-[bis(4-chlorphenyl)acetyl]-argininamide-trifluoracetate;(C) (R)-N-[[4-Aminocarbonylaminomethyl)phenyl]methyl]-N 2-(diphenylacetyl)-argininamide-trifluoracetate;(D) (R)-N 2-(Diphenylacetyl)-N-[[4-(ethoxycarbonylmethylamino-carbonylaminomethyl) phenyl]methyl]-argininamide-trifluoroacetate;(E) (R,S)-N 5-(Aminoiminomethyl)-N 2-(diphenylacetyl)-N-[(4-hy-droxyphenyl)methyl]-N 5-methyl-ornithinamide-hydrochloride; (F) (R)-N-[[4-(Aminocarbonylmethyl)phenyl]methyl]-N 2-(diphenyl-acetyl)-argininamide-diacetate;(G) (R)-N. sup. 2-(Diphenylacetyl)-N-[[4-(ethylaminocarbonylamino-methyl)-phenyl]methyl]-argininamide-bis-(trifluoroacetate); and,(H) (R)-N. sup.2-(Diphenylacetyl)-N-[[4-(ethoxycarbonylamino-carbonylaminomethyl) phenyl]methyl]-argininamide-trifluoroacetate.
